MacularorRetinalEdema near Bronx, NY

Biography: Dr. Kovacs is a board-certified retina specialist and Assistant Professor of Ophthalmology at Weill Cornell Medical College. Dr. Kovacs specializes in the medical and surgical treatment of vitreoretinal diseases, including conditions such as retinal detachment, age-related macular degeneration, diabetic retinopathy, retinal vein occlusions, epiretinal membranes, macular holes, trauma, endophthalmitis, vitreous hemorrhage, retinal degenerations and dystrophies, and secondary intraocular lenses.Dr. Kovacs has lived his whole life in the Northeast, growing up on Amtrak's Northeast Corridor line. A native of New Jersey, he graduated cum laude from Harvard College. He received his M.D. with distinction in clinical research from Albert Einstein College of Medicine, where he was also elected into the Alpha Omega Alpha academic honor society and a recipient of the Jesse S Weissberg Scholarship for Academic Excellence.Dr. Kovacs then completed his Internship Training at Memorial Sloan-Kettering Cancer Center. He completed Residency Training in Ophthalmology at Yale School of Medicine / Yale New Haven Hospital, followed by Fellowship Training in Vitreoretinal Diseases and Surgery at Weill Cornell Medical College / New York Presbyterian Hospital. Dr. Kovacs was selected to serve as Chief Resident during the final year of his residency at Yale, and received multiple awards during his training including Yale ophthalmology resident research awards in 2017 and 2018, New York Academy of Medicine resident research award in 2017, and the Yale Department of Ophthalmology Marvin Sears Award recognizing clinical and surgical excellence.Dr. Kovacs is actively engaged in clinical and basic science research in retinal diseases and has published approximately 25 peer-reviewed research articles. He has authored several textbook chapters and has regularly presents his research at national and international meetings. Dr. Kovacs also serves as scientific reviewer to several major ophthalmology journals.Dr. Kovacs is also actively involved in resident and fellow education and serves as coordinator of retina education for ophthalmology residents at Weill Cornell.Dr. Kovacs is currently accepting new patients. Appointments can be made by calling 646-962-2020.

Care Philosophy: Dr. Park is dedicated to the highest level of eye care and treatment. Her philosophy is that no two eyes are the same, and her objective is to meet each individual's unique vision needs.

Care Philosophy: My colleagues and I at the Weill Cornell Eye Associates are dedicated to delivering the best possible care to our patients We have assembled a world class Ophthalmology department providing state of the art expert care in all of the Ophthalmic sub spe

Biography: Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma. Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008. Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr's efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy's Oncology and Pathology's One network.